-
1
-
-
33746088001
-
Trends in prevalence and outcome of heart failure with preserved ejection fraction
-
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-259.
-
(2006)
N Engl J Med.
, vol.355
, pp. 251-259
-
-
Owan, T.E.1
Hodge, D.O.2
Herges, R.M.3
Jacobsen, S.J.4
Roger, V.L.5
Redfield, M.M.6
-
2
-
-
79952829685
-
Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment
-
Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32:670-679.
-
(2011)
Eur Heart J.
, vol.32
, pp. 670-679
-
-
Borlaug, B.A.1
Paulus, W.J.2
-
3
-
-
84867185889
-
Discriminating clinical features of heart failure with preserved vs reduced ejection fraction in the community
-
Ho JE, Gona P, Pencina MJ, Tu JV, Austin PC, Vasan RS, Kannel WB, D'Agostino RB, Lee DS, Levy D. Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. Eur Heart J. 2012;33:1734-1741.
-
(2012)
Eur Heart J.
, vol.33
, pp. 1734-1741
-
-
Ho, J.E.1
Gona, P.2
Pencina, M.J.3
Tu, J.V.4
Austin, P.C.5
Vasan, R.S.6
Kannel, W.B.7
D'agostino, R.B.8
Lee, D.S.9
Levy, D.10
-
4
-
-
76849111852
-
Natriuretic peptides in heart failure: Should therapy be guided by BNP levels?
-
O'Donoghue M, Braunwald E. Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol. 2010;7:13-20.
-
(2010)
Nat Rev Cardiol
, vol.7
, pp. 13-20
-
-
O'donoghue, M.1
Braunwald, E.2
-
5
-
-
84875766051
-
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction
-
van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG, Paulus WJ, Voors AA, Hillege HL. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol. 2013;61:1498-1506.
-
(2013)
J Am Coll Cardiol.
, vol.61
, pp. 1498-1506
-
-
Van Veldhuisen, D.J.1
Linssen, G.C.2
Jaarsma, T.3
Van Gilst, W.H.4
Hoes, A.W.5
Tijssen, J.G.6
Paulus, W.J.7
Voors, A.A.8
Hillege, H.L.9
-
6
-
-
84879748718
-
A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation
-
Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62:263-271.
-
(2013)
J Am Coll Cardiol.
, vol.62
, pp. 263-271
-
-
Paulus, W.J.1
Tschöpe, C.2
-
7
-
-
84867892494
-
Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction
-
Akiyama E, Sugiyama S, Matsuzawa Y, Konishi M, Suzuki H, Nozaki T, Ohba K, Matsubara J, Maeda H, Horibata Y, Sakamoto K, Sugamura K, Yamamuro M, Sumida H, Kaikita K, Iwashita S, Matsui K, Kimura K, Umemura S, Ogawa H. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol. 2012;60:1778-1786.
-
(2012)
J Am Coll Cardiol.
, vol.60
, pp. 1778-1786
-
-
Akiyama, E.1
Sugiyama, S.2
Matsuzawa, Y.3
Konishi, M.4
Suzuki, H.5
Nozaki, T.6
Ohba, K.7
Matsubara, J.8
Maeda, H.9
Horibata, Y.10
Sakamoto, K.11
Sugamura, K.12
Yamamuro, M.13
Sumida, H.14
Kaikita, K.15
Iwashita, S.16
Matsui, K.17
Kimura, K.18
Umemura, S.19
Ogawa, H.20
more..
-
8
-
-
77956330748
-
Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction
-
Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2010;56:845-854.
-
(2010)
J Am Coll Cardiol.
, vol.56
, pp. 845-854
-
-
Borlaug, B.A.1
Olson, T.P.2
Lam, C.S.3
Flood, K.S.4
Lerman, A.5
Johnson, B.D.6
Redfield, M.M.7
-
9
-
-
84871043342
-
Von Willebrand factor: The old, the new and the unknown
-
Lenting PJ, Casari C, Christophe OD, Denis CV. von Willebrand factor: the old, the new and the unknown. J Thromb Haemost. 2012;10:2428-2437.
-
(2012)
J Thromb Haemost.
, vol.10
, pp. 2428-2437
-
-
Lenting, P.J.1
Casari, C.2
Christophe, O.D.3
Denis, C.V.4
-
10
-
-
84857766493
-
Endothelium-role in regulation of coagulation and inflammation
-
van Hinsbergh VW. Endothelium-role in regulation of coagulation and inflammation. Semin Immunopathol. 2012;34:93-106.
-
(2012)
Semin Immunopathol.
, vol.34
, pp. 93-106
-
-
Van Hinsbergh, V.W.1
-
11
-
-
0028909230
-
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
-
European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
-
Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332:635-641.
-
(1995)
N Engl J Med.
, vol.332
, pp. 635-641
-
-
Thompson, S.G.1
Kienast, J.2
Pyke, S.D.3
Haverkate, F.4
Van De Loo, J.C.5
-
12
-
-
70449338756
-
Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure
-
Gombos T, Makó V, Cervenak L, Papassotiriou J, Kunde J, Hársfalvi J, Förhécz Z, Pozsonyi Z, Borgulya G, Jánoskuti L, Prohászka Z. Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure. Thromb Haemost. 2009;102:573-580.
-
(2009)
Thromb Haemost.
, vol.102
, pp. 573-580
-
-
Gombos, T.1
Makó, V.2
Cervenak, L.3
Papassotiriou, J.4
Kunde, J.5
Hársfalvi, J.6
Förhécz, Z.7
Pozsonyi, Z.8
Borgulya, G.9
Jánoskuti, L.10
Prohászka, Z.11
-
13
-
-
0034937299
-
Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease
-
LURIC Study Group (LUdwigshafen RIsk and Cardiovascular Health)
-
Winkelmann BR, März W, Boehm BO, Zotz R, Hager J, Hellstern P, Senges J; LURIC Study Group (LUdwigshafen RIsk and Cardiovascular Health). Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics. 2001;2(1 suppl 1):S1-73.
-
(2001)
Pharmacogenomics.
, vol.2
, Issue.1
, pp. S1-73
-
-
Winkelmann, B.R.1
März, W.2
Boehm, B.O.3
Zotz, R.4
Hager, J.5
Hellstern, P.6
Senges, J.7
-
14
-
-
78649477601
-
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
-
Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11-21.
-
(2011)
Stat Med.
, vol.30
, pp. 11-21
-
-
Pencina, M.J.1
Steyerberg, E.W.2
-
15
-
-
33646771330
-
Von Willebrand factor, endothelial dysfunction, and cardiovascular disease
-
Vischer UM. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost. 2006;4:1186-1193.
-
(2006)
J Thromb Haemost.
, vol.4
, pp. 1186-1193
-
-
Vischer, U.M.1
-
16
-
-
12844253061
-
Endothelial function: Cardiac events
-
Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363-368.
-
(2005)
Circulation.
, vol.111
, pp. 363-368
-
-
Lerman, A.1
Zeiher, A.M.2
-
17
-
-
3042839778
-
Effects of inflammatory cytokines on the release and cleavage of the endothelial cellderived ultralarge von Willebrand factor multimers under flow
-
Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelial cellderived ultralarge von Willebrand factor multimers under flow. Blood. 2004;104:100-106.
-
(2004)
Blood.
, vol.104
, pp. 100-106
-
-
Bernardo, A.1
Ball, C.2
Nolasco, L.3
Moake, J.F.4
Dong, J.F.5
-
18
-
-
0035957410
-
Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factordeficient mice
-
Denis CV, André P, Saffaripour S, Wagner DD. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factordeficient mice. Proc Natl Acad Sci U S A. 2001;98:4072-4077.
-
(2001)
Proc Natl Acad Sci U S A.
, vol.98
, pp. 4072-4077
-
-
Denis, C.V.1
André, P.2
Saffaripour, S.3
Wagner, D.D.4
-
19
-
-
78649471507
-
Von Willebrand factor promotes leukocyte extravasation
-
Petri B, Broermann A, Li H, Khandoga AG, Zarbock A, Krombach F, Goerge T, Schneider SW, Jones C, Nieswandt B, Wild MK, Vestweber D. von Willebrand factor promotes leukocyte extravasation. Blood. 2010;116:4712-4719.
-
(2010)
Blood.
, vol.116
, pp. 4712-4719
-
-
Petri, B.1
Broermann, A.2
Li, H.3
Khandoga, A.G.4
Zarbock, A.5
Krombach, F.6
Goerge, T.7
Schneider, S.W.8
Jones, C.9
Nieswandt, B.10
Wild, M.K.11
Vestweber, D.12
-
20
-
-
84890082782
-
Biomarkers of heart failure with normal ejection fraction: A systematic review
-
Cheng JM, Akkerhuis KM, Battes LC, van Vark LC, Hillege HL, Paulus WJ, Boersma E, Kardys I. Biomarkers of heart failure with normal ejection fraction: a systematic review. Eur J Heart Fail. 2013;15:1350-1362.
-
(2013)
Eur J Heart Fail.
, vol.15
, pp. 1350-1362
-
-
Cheng, J.M.1
Akkerhuis, K.M.2
Battes, L.C.3
Van Vark, L.C.4
Hillege, H.L.5
Paulus, W.J.6
Boersma, E.7
Kardys, I.8
-
21
-
-
49349117049
-
Inflammatory pathways in patients with heart failure and preserved ejection fraction
-
Niethammer M, Sieber M, von Haehling S, Anker SD, Munzel T, Horstick G, Genth-Zotz S. Inflammatory pathways in patients with heart failure and preserved ejection fraction. Int J Cardiol. 2008;129:111-117.
-
(2008)
Int J Cardiol.
, vol.129
, pp. 111-117
-
-
Niethammer, M.1
Sieber, M.2
Von Haehling, S.3
Anker, S.D.4
Munzel, T.5
Horstick, G.6
Genth-Zotz, S.7
-
22
-
-
84903777188
-
C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction
-
Koller L, Kleber M, Goliasch G, Sulzgruber P, Scharnagl H, Silbernagel G, Grammer T, Delgado G, Tomaschitz A, Pilz S, März W, Niessner A. C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction. Eur J Heart Fail. 2014;16:758-766.
-
(2014)
Eur J Heart Fail.
, vol.16
, pp. 758-766
-
-
Koller, L.1
Kleber, M.2
Goliasch, G.3
Sulzgruber, P.4
Scharnagl, H.5
Silbernagel, G.6
Grammer, T.7
Delgado, G.8
Tomaschitz, A.9
Pilz, S.10
März, W.11
Niessner, A.12
-
23
-
-
32844474144
-
Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes
-
Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GY. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Am J Cardiol. 2006;97:671-675.
-
(2006)
Am J Cardiol.
, vol.97
, pp. 671-675
-
-
Chong, A.Y.1
Freestone, B.2
Patel, J.3
Lim, H.S.4
Hughes, E.5
Blann, A.D.6
Lip, G.Y.7
-
24
-
-
33847780361
-
Viewpoint: The prothrombotic state in heart failure: A maladaptive inflammatory response?
-
Chong AY, Lip GY. Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response? Eur J Heart Fail. 2007;9:124-128.
-
(2007)
Eur J Heart Fail
, vol.9
, pp. 124-128
-
-
Chong, A.Y.1
Lip, G.Y.2
-
25
-
-
70449416759
-
Systolic heart failure: A prothrombotic state
-
de Peuter OR, Kok WE, Torp-Pedersen C, Büller HR, Kamphuisen PW. Systolic heart failure: a prothrombotic state. Semin Thromb Hemost. 2009;35:497-504.
-
(2009)
Semin Thromb Hemost.
, vol.35
, pp. 497-504
-
-
De Peuter, O.R.1
Kok, W.E.2
Torp-Pedersen, C.3
Büller, H.R.4
Kamphuisen, P.W.5
-
26
-
-
84878339678
-
How do patients with heart failure with preserved ejection fraction die?
-
Chan MM, Lam CS. How do patients with heart failure with preserved ejection fraction die? Eur J Heart Fail. 2013;15:604-613.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 604-613
-
-
Chan, M.M.1
Lam, C.S.2
-
27
-
-
0027236046
-
Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. the Atherosclerosis Risk in Communities (ARIC) Study
-
Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost. 1993;70:380-385.
-
(1993)
Thromb Haemost.
, vol.70
, pp. 380-385
-
-
Conlan, M.G.1
Folsom, A.R.2
Finch, A.3
Davis, C.E.4
Sorlie, P.5
Marcucci, G.6
Wu, K.K.7
-
28
-
-
54949128659
-
Endothelial activation markers in anemic non-dialysis chronic kidney disease patients
-
Patel TV, Mittal BV, Keithi-Reddy SR, Duffield JS, Singh AK. Endothelial activation markers in anemic non-dialysis chronic kidney disease patients. Nephron Clin Pract. 2008;110:c244-c250.
-
(2008)
Nephron Clin Pract.
, vol.110
, pp. c244-c250
-
-
Patel, T.V.1
Mittal, B.V.2
Keithi-Reddy, S.R.3
Duffield, J.S.4
Singh, A.K.5
-
29
-
-
79958796133
-
Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients
-
Roldán V, Marín F, Muiña B, Torregrosa JM, Hernández-Romero D, Valdés M, Vicente V, Lip GY. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients. J Am Coll Cardiol. 2011;57:2496-2504.
-
(2011)
J Am Coll Cardiol.
, vol.57
, pp. 2496-2504
-
-
Roldán, V.1
Marín, F.2
Muiña, B.3
Torregrosa, J.M.4
Hernández-Romero, D.5
Valdés, M.6
Vicente, V.7
Lip, G.Y.8
|